Key Takeaways
- • Brevan Howard's flagship Master Fund delivered only +0.8% return in 2025, dramatically underperforming the macro hedge fund surge that generated an estimated $543 billion in industry-wide gains, an all-time record.
- • Peers substantially outpaced Brevan Howard across the board: Bridgewater's Pure Alpha posted approximately +33%, Discovery Capital's macro fund ~+36%, Rokos +21%, and D.E. Shaw's macro arm ~28%, signaling fundamental strategic gaps at the London-based firm.
- • January 2025 proved particularly damaging, with the Master Fund falling 2.93% as interest-rate uncertainty and FX trades backfired, erasing prior-year gains and suggesting directional bets went against key market moves during unprecedented volatility.
- • Brevan Howard is shutting its $1.4 billion Brevan Howard FG Fund, run by Fash Golchin, with external capital operations to cease by end-June 2026, reflecting management's response to weak 2025 performance across the firm's portfolio.
- • The macro environment in 2025 was exceptionally favorable for active traders, driven by extreme volatility, ongoing geopolitical conflicts, supply-chain disruptions, aggressive Fed policy shifts, and political shocks including Trump administration tariff policies—conditions Brevan Howard failed to capitalize on.
Summary
Brevan Howard Asset Management significantly underperformed during 2025, a banner year for macro hedge funds globally. The firm's flagship Master Fund, one of the industry's largest, returned only +0.8% for the year, with its Alpha Strategies fund posting +8.0%. This represents a stark underperformance against the macro hedge fund surge that generated an estimated $543 billion in industry-wide gains—an all-time record according to Bloomberg survey data. The divergence is particularly acute given that competitive advantages in macro trading were pronounced throughout 2025.
The performance gap versus peers was substantial across multiple prominent managers. Bridgewater Associates' flagship Pure Alpha fund posted approximately +33% in 2025, while Discovery Capital's macro fund achieved roughly +36%. Even smaller, more specialized competitors outpaced Brevan Howard significantly: Rokos returned 21%, D.E. Shaw's macro arm approximately 28%, and Sir Chris Hohn's TCI Fund Management captured $18.9 billion of the industry's total gains. These results indicate that Brevan Howard's strategic positioning failed to capture the alpha generation opportunities available to competitors who executed more effectively.
January 2025 crystallized the firm's tactical missteps. The Master Fund declined 2.93% during the month alone as interest-rate uncertainty and foreign exchange trades resulted in losses, erasing a substantial portion of 2024's gains. This pattern suggests Brevan Howard's traders took directional positions opposite to actual market movements during a period characterized by exceptional volatility and clear macro trend developments. The macro environment itself was richly favorable for active managers, driven by unprecedented volatility, ongoing geopolitical conflicts, fraying supply chains, aggressive Federal Reserve policy changes, and political shocks including renewed tariff policies under the Trump administration.
In response to 2025's weak performance, Brevan Howard is implementing structural changes. Bloomberg reported that the firm will close the $1.4 billion Brevan Howard FG Fund managed by Fash Golchin, with external capital operations ceasing by end-June 2026. This decision reflects management's acknowledgment of performance headwinds and represents a strategic reallocation toward flagship fund operations. The closure signals that despite the favorable macro environment, Brevan Howard's portfolio structure and trading execution did not generate returns commensurate with market opportunities available to competitors.
The performance gap versus peers was substantial across multiple prominent managers. Bridgewater Associates' flagship Pure Alpha fund posted approximately +33% in 2025, while Discovery Capital's macro fund achieved roughly +36%. Even smaller, more specialized competitors outpaced Brevan Howard significantly: Rokos returned 21%, D.E. Shaw's macro arm approximately 28%, and Sir Chris Hohn's TCI Fund Management captured $18.9 billion of the industry's total gains. These results indicate that Brevan Howard's strategic positioning failed to capture the alpha generation opportunities available to competitors who executed more effectively.
January 2025 crystallized the firm's tactical missteps. The Master Fund declined 2.93% during the month alone as interest-rate uncertainty and foreign exchange trades resulted in losses, erasing a substantial portion of 2024's gains. This pattern suggests Brevan Howard's traders took directional positions opposite to actual market movements during a period characterized by exceptional volatility and clear macro trend developments. The macro environment itself was richly favorable for active managers, driven by unprecedented volatility, ongoing geopolitical conflicts, fraying supply chains, aggressive Federal Reserve policy changes, and political shocks including renewed tariff policies under the Trump administration.
In response to 2025's weak performance, Brevan Howard is implementing structural changes. Bloomberg reported that the firm will close the $1.4 billion Brevan Howard FG Fund managed by Fash Golchin, with external capital operations ceasing by end-June 2026. This decision reflects management's acknowledgment of performance headwinds and represents a strategic reallocation toward flagship fund operations. The closure signals that despite the favorable macro environment, Brevan Howard's portfolio structure and trading execution did not generate returns commensurate with market opportunities available to competitors.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.